GeneVentiv to Attend Biotech Showcase

GeneVentiv to Attend Biotech Showcase

November 30, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood disorders, today announced it will attend the Biotech Showcase and BIO Partnering meetings during the J.P. Morgan...
GeneVentiv Therapeutics to Attend BIO Europe Fall 2023

GeneVentiv Therapeutics to Attend BIO Europe Fall 2023

October 10, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood disorders, today announced it will attend BIO Europe Fall 2023, which will be held from November 14-15, 2023.  GeneVentiv...
GeneVentiv to Attend BIO Investor Forum

GeneVentiv to Attend BIO Investor Forum

October 2, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood disorders, today announced it will attend BIO Investor Forum, which will be held in San Francisco, CA from October 17-18,...
GeneVentiv Invited to Present at BioPharm America 2023

GeneVentiv Invited to Present at BioPharm America 2023

August 30, 2023 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood diseases and disorders, today announced it has been invited to present at BioPharm AmericaTM, which will be held in Raleigh,...